Milestone Scientific Inc. (NYSEAMERICAN:MLSS) CFO Joseph D’agostino sold 52,980 shares of the stock in a transaction on Wednesday, December 13th. The stock was sold at an average price of $1.05, for a total transaction of $55,629.00. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Joseph D’agostino also recently made the following trade(s):

  • On Tuesday, December 5th, Joseph D’agostino sold 15,000 shares of Milestone Scientific stock. The stock was sold at an average price of $1.05, for a total transaction of $15,750.00.

Shares of Milestone Scientific Inc. (NYSEAMERICAN:MLSS) traded up $0.00 during trading hours on Friday, hitting $0.99. The stock had a trading volume of 16,179 shares, compared to its average volume of 77,328. Milestone Scientific Inc. has a 12 month low of $0.91 and a 12 month high of $1.80.

Several equities research analysts have recently issued reports on the company. Maxim Group reaffirmed a “buy” rating and issued a $4.00 price target on shares of Milestone Scientific in a research report on Friday, October 6th. ValuEngine raised Milestone Scientific from a “sell” rating to a “hold” rating in a research report on Friday, September 8th.

TRADEMARK VIOLATION WARNING: This report was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another site, it was stolen and reposted in violation of US and international trademark & copyright law. The legal version of this report can be accessed at

Milestone Scientific Company Profile

Milestone Scientific Inc (Milestone) is engaged in providing computer-controlled injection technologies and solutions for the medical and dental markets. The Company uses its CompuFlo technology for the delivery of medicaments. The CompuFlo pressure or force Computer-Controlled Local Anesthetic Delivery (C-CLAD) technology is a medical technology for the delivery of drugs, anesthetics and other medicaments into various tissue types.

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with's FREE daily email newsletter.